Filipíny - angličtina - FDA (Food And Drug Administration)

savcus inc - ketorolac trometamol - solution for injection (im/iv) - 30mg/ ml

Filipíny - angličtina - FDA (Food And Drug Administration)

h & b pharma international, inc.; distributor: savcus inc. - cefuroxime (as sodium) - powder for injection - 750 mg

Spojené štáty - angličtina - NLM (National Library of Medicine)

physicians total care, inc. - granisetron (unii: wzg3j2mcol) (granisetron - unii:wzg3j2mcol) - granisetron 3.1 mg in 24 h - sancuso® (granisetron transdermal system) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration. sancuso is contraindicated in patients with known hypersensitivity to granisetron or to any of the components of the patch. pregnancy category b reproduction studies with granisetron hydrochloride have been performed in pregnant rats at intravenous doses up to 9 mg/kg/day (54 mg/m2 /day, about 24 times the recommended human dose delivered by the sancuso patch, based on body surface area) and oral doses up to 125 mg/kg/day (750 mg/m2 /day, about 326 times the recommended human dose with sancuso based on body surface area). reproduction studies have been performed in pregnant rabbits at intravenous doses up to 3 mg/kg/day (36 mg/m2 /day, about 16 times the human dose with sancuso based on body surface area) and at oral doses up to 32 mg/kg/day (384 mg/m2 /day, about 167 times the human dose with san

Spojené štáty - angličtina - NLM (National Library of Medicine)

kyowa kirin, inc. - granisetron (unii: wzg3j2mcol) (granisetron - unii:wzg3j2mcol) - granisetron 3.1 mg in 24 h - sancuso® is indicated for the prevention of nausea and vomiting in adults receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration. sancuso is contraindicated in patients with known hypersensitivity to granisetron or to any of the components of the transdermal system [see description (10)] . risk summary available published data and postmarketing reports with granisetron use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in a published ex vivo human placental perfusion model, no transplacental passage of granisetron was detected at a concentration (5 ng/ml) that mimics the plasma concentration achieved following transdermal application of sancuso. in animal reproduction studies, no adverse developmental effects were observed in pregnant rats and rabbits administered granisetron hydrochloride during organogenesis at intravenous doses up to 24 times and 16 times, respective

Spojené štáty - angličtina - NLM (National Library of Medicine)

j. a. cosmetics u.s. inc - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - zinc cation 25 g in 100 ml - purpose: sunscreen uses: helps prevent sunburn if used as directed (see directions), decreases the risk of skin cancer and early skin aging caused by the sun.

Spojené štáty - angličtina - NLM (National Library of Medicine)

autumn harp, inc. - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - zinc oxide 3.2 mg in 100 ml - sunscreen helps prevent sunburn • if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Spojené štáty - angličtina - NLM (National Library of Medicine)

autumn harp, inc - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - zinc oxide 3.2 mg in 100 ml - sunscreen helps prevent sunburn • if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Spojené štáty - angličtina - NLM (National Library of Medicine)

emeis cosmetics pty ltd - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide 0.26 g in 1.54 g - sunscreen - helps prevent sunburn.

Spojené štáty - angličtina - NLM (National Library of Medicine)

spa de soleil - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide 0.13 mg in 2.5 ml - sunscreen helps prevent sunburn. higher spf gives more sunburn protection. if used as directed with other sun protection measures (see sun alert) decreases the risk of skin cancer and early skin aging caused by the sun. sun alert: spending time in the use increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad-spectrum spf value of 15 or higher and other sun protection measures such as limited time in the sun, especially from 10 a.m. to 2 p.m. wear long pants, hats, sunglasses, and long-sleeve shirts.

Európska únia - angličtina - EMA (European Medicines Agency)

kyowa kirin holdings b.v. - granisetron - vomiting; cancer - antiemetics and antinauseants, , serotonin (5ht3) antagonists - prevention of nausea and vomiting in patients receiving moderately or highly emetogenic chemotherapy, with or without cisplatin, for up to five consecutive days.sancuso may be used in patients receiving their first chemotherapy regimen or in patients who have previously received chemotherapy.